Cystosarcoma phyllodes are treated by
**Question:** Cystosarcoma phyllodes are treated by
A. Radiotherapy
B. Chemotherapy
C. Surgery
D. Hormone therapy
**Correct Answer:** C. Surgery
**Core Concept:** Cystosarcoma phyllodes is a rare type of soft tissue sarcoma that occurs in the breast tissue. It is characterized by the presence of a cyst wall that contains numerous layers of cells resembling the leaves of a phyllodes plant, giving the tumor its name.
**Why the Correct Answer is Right:** Cystosarcoma phyllodes is primarily treated with surgery, as it is a localized tumor that can be surgically removed. The goal of surgery is to achieve wide local excision with clear margins and potentially adjuvant therapy, such as radiation therapy (Radiotherapy) or chemotherapy (Chemotherapy), depending on the tumor size, grade, and margins. In high-grade tumors or tumors with positive margins, radiation therapy may be used to reduce the risk of local recurrence. Chemotherapy is typically not the primary treatment modality for cystosarcoma phyllodes but can be used for palliation or for patients with inoperable tumors.
**Why Each Wrong Option is Incorrect:**
A. Radiotherapy (Option A) is used in conjunction with surgery to reduce the risk of local recurrence. It is not a primary treatment modality for cystosarcoma phyllodes.
B. Chemotherapy (Option B) is typically not the primary treatment modality for cystosarcoma phyllodes but can be used for palliation or for patients with inoperable tumors.
D. Hormone therapy (Option D) is not a relevant treatment option for cystosarcoma phyllodes, as it is a malignant tumor and not related to hormonal therapy.
**Clinical Pearl:** Cystosarcoma phyllodes is a rare but aggressive tumor that can be challenging to manage. Surgery remains the primary treatment modality, with adjuvant treatments tailored based on tumor characteristics. Informed decision-making and multidisciplinary approach among surgeons, oncologists, and radiation oncologists are essential to provide the best possible care for patients with cystosarcoma phyllodes.